Company: Oncolytics Biotech Inc. Symbol: TSX: ONC Length: 00:19:39 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in late stage …
Oncolytics Biotech – Development of Oncolytic Viruses Read More »